Qu Ying, Chang Lisa, Klaff Justin, Seeman Ruth, Balbo Andrea, Rapoport Stanley I
Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Building 10, Rm. 6N202, Bethesda, MD 20892, USA.
Brain Res Brain Res Protoc. 2003 Aug;12(1):16-25. doi: 10.1016/s1385-299x(03)00057-6.
In vitro studies have shown that 5-HT2 receptors can be coupled via G-proteins to phospholipase A2 (PLA2) activation, releasing arachidonic acid from phospholipids. To examine this signaling pathway in brain, we developed an in vivo method to image regional brain PLA2 activation in unanesthetized rats given different types of serotonergic drugs. Increased arachidonate incorporation from plasma, in response to drug-induced PLA2-activation, can be quantified with autoradiography, following the intravenous injection of radiolabeled arachidonate. For example, a 5-HT(2A/2C) receptor agonist, (+/-)-2,5-dimethoxy-4-iodophenyl-2-aminopropane, produced widespread increases in incorporation of labeled arachidonate by directly binding to 5-HT(2A/2C) receptors. Fluoxetine, a selective serotonin reuptake inhibitor, selectively increased incorporation of arachidonic acid by increasing 5-HT availability in the synaptic cleft and thus indirectly activating phospholipase A2. The detailed method is described.
